Australia markets closed

GT Biopharma, Inc. (GTBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8300+0.0100 (+0.35%)
At close: 04:00PM EDT
2.7700 -0.06 (-2.12%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.10M
Enterprise value -3.67M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.15
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.09

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-70.52%
S&P500 52-week change 322.55%
52-week high 310.9500
52-week low 32.6000
50-day moving average 33.4422
200-day moving average 35.5270

Share statistics

Avg vol (3-month) 31.38M
Avg vol (10-day) 387.13k
Shares outstanding 52.16M
Implied shares outstanding 62.16M
Float 81.13M
% held by insiders 16.67%
% held by institutions 115.67%
Shares short (14 June 2024) 432.02k
Short ratio (14 June 2024) 40.01
Short % of float (14 June 2024) 41.52%
Short % of shares outstanding (14 June 2024) 41.48%
Shares short (prior month 15 May 2024) 42.73k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 321 Aug 2017
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 305 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-54.18%
Return on equity (ttm)-104.94%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-9.64M
Diluted EPS (ttm)-7.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.81M
Total cash per share (mrq)6.92
Total debt (mrq)30k
Total debt/equity (mrq)0.57%
Current ratio (mrq)2.15
Book value per share (mrq)3.85

Cash flow statement

Operating cash flow (ttm)-10.11M
Levered free cash flow (ttm)-6.08M